Search this site

The US is preparing up to $7 billion in financing for Argentine minerals and energy projects. Investors need to see which projects receive support and what it helps them build. The United States is preparing to support up to $7 billion in critical minerals and energy projects in Argentina, according to a document seen by Reuters. The proposed financing could help developers buy equipment from American manufacturers over the next two years. For investors, the important word is “up to.” This is a financing plan, not $7 billion already spent or a guarantee that every project will move forward. Where the money could matter Argentina has substantial lithium resources, copper projects and shale energy operations. Rio Tinto extracts lithium there, BHP is developing a copper project, and Chevron has a major shale operation. US-backed financing could make it easier for qualifying projects to purchase equipment and move through the next stage of development. It could also create business for American suppliers. But the size of the announcement alone tells investors little about which companies will benefit. Individual loans, project costs and development schedules will matter more than the headline figure. That is the question to follow as details emerge: which projects receive financing, and does it bring production closer? Until those answers are clear, the plan is a potential source of momentum rather than new mineral supply investors can count on.

SoftBank is raising approximately $11 billion through one of the year’s largest corporate bond sales, using debt markets to finance its expanding investment in OpenAI and the wider artificial intelligence boom. SoftBank is turning to the bond market to finance its growing artificial intelligence ambitions. The Japanese investment group has launched approximately $11 billion in dollar- and euro-denominated bonds. Most of the proceeds will fund the next stage of its investment in OpenAI. The offering includes $10 billion in US dollar bonds and €1 billion in euro bonds, spread across several maturities. If completed as planned, it would become the largest bond sale by a non-financial company in the Asia-Pacific and Japan region. SoftBank will use the proceeds to replace a $10 billion bridge loan arranged for its upcoming OpenAI payment. That investment tranche is expected to close on October 1. The transaction demonstrates how much capital is now being committed to artificial intelligence. OpenAI requires enormous funding to develop new models, secure computing capacity and expand its infrastructure. For SoftBank, the investment could provide substantial exposure to one of the world’s most valuable AI companies. However, financing that position with debt also increases the risk if OpenAI’s growth fails to meet expectations. Fitch assigned the proposed bonds a BB+ rating. The agency expects SoftBank’s debt to rise but believes the company still has strong liquidity and access to capital markets. The bond sale also tests investor appetite for financing the AI boom. Strong demand would suggest lenders remain willing to support major technology investments despite uncertainty over when the spending will produce sustainable returns. SoftBank has repeatedly made large, concentrated bets on emerging technologies. Its latest financing shows that OpenAI now sits at the centre of that strategy. For investors, the opportunity is significant, but so is the exposure. SoftBank is not simply investing in AI growth. It is placing billions of dollars behind OpenAI’s ability to deliver it.

An FDA panel is reviewing Grail’s Galleri cancer blood test today. Its view on whether the evidence supports “early detection” could prove as important as its overall recommendation. Grail’s Galleri blood test is designed to look for signals from more than 50 types of cancer. Today, an FDA advisory panel is reviewing the company’s application for approval. The question goes beyond whether the test can find cancer: does the evidence support calling it an early-detection test? That distinction matters to patients, doctors and investors. Detecting a cancer signal is valuable only if it leads to useful care; finding cancers earlier is central to Grail’s case for broader use. Why the wording matters FDA staff have asked the panel to examine how Galleri performs across cancer types and stages, and whether the results justify the word “early” in its proposed use. They have also asked advisers to consider a description without that word if the evidence does not support it. The review comes with a significant complication. In a large UK trial, routine use of Galleri did not significantly improve early detection or reduce late-stage cancer diagnoses across the trial’s main measures, according to Reuters. The test is already available in the US through a laboratory pathway, but it does not have FDA approval. The panel’s recommendation will be an important signal, though the FDA makes the final approval decision. Investors should watch both what the panel recommends and what claims it believes Galleri can support. Those details will shape how Grail can present the test to doctors and patients.

McDonald’s plans $8.5 billion in franchisee support, but expects flat industry traffic while inflation remains high. Investors should watch whether restaurant upgrades improve returns enough to win franchisee support. McDonald’s has laid out a plan to bring customers back more often. The company expects to provide about $8.5 billion in rent relief and capital support to franchisees through 2036 as it upgrades restaurants and improves operations. But it also expects customer traffic across the industry in its wholly owned markets to remain flat while inflation stays high. That leaves investors with a practical question: will the upgrades earn enough to make franchisees want to carry them out? Follow the restaurant economics McDonald’s estimates that its changes could eventually add about $100,000 in annual cash flow for the average US restaurant through greater efficiency. It projects an approximately four-year payback for franchisees after its support. Those are targets, not results already achieved. Franchisees still face substantial costs. Reuters reported that required US restaurant remodels and other upgrades could cost at least $1.2 million for an average location, and that McDonald’s support does not cover the remodel itself. Franchisee participation matters because most McDonald’s restaurants are independently operated. The plan aims to make restaurants faster and easier to run. For shareholders, the proof will come from more visits and better restaurant returns, not the size of the spending commitment. If traffic stays flat, even a more efficient restaurant has a harder job delivering growth.

Apple is pitching its new Macs as a way for businesses to run some AI work locally. The investor test is whether the savings and performance can win over corporate buyers. Apple’s new Mac mini and Mac Studio are now on sale, and the company is making a pitch that goes beyond faster computers: businesses could run some AI tasks on their own machines instead of paying for every task through a cloud service. That makes the new Macs part of a bigger question for investors. How much AI work will companies choose to run locally? A different way to pay for AI Cloud AI services charge according to usage. A desktop requires an upfront purchase but can run suitable tasks repeatedly without a charge for each request. Apple’s Mac Studio starts at $2,499, with a more powerful version starting at $5,499. The company says its new machines are built for demanding work, including AI tasks performed on the device. The potential opening is real, but so is the challenge. Apple holds about 4.6% of the enterprise desktop and laptop market, compared with 91.3% for Windows, according to IDC figures reported by Reuters. Microsoft and Nvidia are pursuing AI work on PCs too. Apple does not need to replace the cloud to make this worthwhile. It needs to show businesses that enough of their everyday AI work can run effectively on Macs to justify buying them. Corporate adoption, rather than a product demonstration, will tell investors whether this becomes a meaningful new source of demand.

YouTube is taking its shopping affiliate programme to 35 countries after reporting rapid growth in goods sold through it. Investors still need to know how much of that activity becomes revenue for Alphabet. YouTube wants a larger role in what happens after someone watches a product review. It plans to expand its shopping affiliate programme to 35 countries by year-end, letting more creators earn commissions by tagging products in videos, livestreams and Shorts. For Alphabet investors, the opportunity is clear: YouTube already has viewers researching what to buy. Product tags could help turn that attention into purchases while giving creators another reason to build their businesses on the platform. Big growth, with one missing figure YouTube says more than 1.3 million creators are in the affiliate programme and that the value of goods sold through it has grown 13-fold over two years. It is also adding tools to show viewers offers relevant to their country. Those figures show growing use. They do not reveal how much revenue shopping generates for YouTube, how profitable it is, or whether it is large enough to change Alphabet’s results. The 13-fold figure describes merchandise value, not money retained by the company. That is the investor angle to follow as the programme expands. Can YouTube convert creator recommendations into a meaningful business of its own? Growth in tagged purchases is a promising sign; disclosed revenue and profit would be stronger proof.

Novo Nordisk is targeting more than $23 billion in pipeline sales by 2035, but investors remain cautious as competition, pricing pressure and future patent expirations threaten the company’s long-term growth. Novo Nordisk has outlined an ambitious plan to launch more than five blockbuster medicines by 2030, but investors remain concerned about the company’s future beyond Ozempic and Wegovy. The Danish pharmaceutical group is targeting more than 150 billion Danish crowns, approximately $23 billion, in annual pipeline sales by 2035. It also wants to reach more than 60 million patients globally by 2030 and expand its manufacturing capacity for oral obesity treatments. Despite those targets, Novo shares fell as much as 9% as investors questioned its pricing power, acquisition strategy and ability to develop successors to its most valuable medicines. The reaction reflects the pressure building around Novo’s pipeline. Ozempic and Wegovy transformed the company into a global leader in obesity and diabetes care. However, both contain semaglutide, which is expected to begin losing patent protection in major markets during the early 2030s. Novo now has several years to build its next generation of treatments. The company plans to begin with CagriSema, a combination obesity medicine targeted for launch in early 2027. Standalone cagrilintide and a higher-dose version of CagriSema could follow in 2028, with further treatments expected later. Oral medicines will also play a central role. Novo aims to have at least five oral treatments in clinical trials by the end of 2026, potentially allowing it to reach patients who prefer tablets over weekly injections. Demand already appears strong. The company said oral Wegovy has reached seven million US prescriptions, with approximately 90% coming through direct cash-payment channels. However, expanding access could place additional pressure on pricing. Reaching tens of millions of patients may require lower-cost treatments, meaning higher prescription volumes will not automatically produce the same level of profit growth. Competition is another concern. Eli Lilly continues to expand its own obesity portfolio, increasing the pressure on Novo to deliver treatments that are more effective, convenient or affordable. For investors, Novo’s challenge is no longer proving that obesity medicines can become blockbuster products. It must show that it can defend its position while building a pipeline capable of replacing semaglutide as patent protection weakens. The company has presented an ambitious route forward. The sharp decline in its shares suggests investors now want stronger evidence that it can deliver.

Starbucks plans to hire around 800 technology professionals at a new centre in India, strengthening the digital systems behind its global stores, loyalty programme and wider customer experience. Starbucks plans to hire around 800 technology professionals in India as it strengthens the digital systems supporting its global café network. The company has signed an agreement to establish a global capability centre in Chennai. The size of the investment has not been disclosed, but the facility is expected to support software development, finance and research. For investors, the expansion shows how technology is becoming increasingly important to Starbucks’ wider business strategy. The company may be best known for coffee, but much of its customer experience now depends on digital infrastructure. Mobile ordering, loyalty rewards, personalised promotions, payments and store operations all rely on technology working smoothly behind the scenes. A dedicated technology centre could give Starbucks greater control over those systems while providing access to India’s large pool of skilled workers. India has become the world’s largest market for global capability centres, with more than 2,100 facilities employing approximately 2.36 million people. Companies increasingly use these centres for higher-value work, including software engineering, product development and research. Chennai represents around 10% of India’s capability-centre market. Starbucks technology chief Anand Varadarajan highlighted the city’s skilled workforce, infrastructure and comparatively low employee turnover. The investment also comes as Starbucks expands its consumer business in India. The company operates approximately 500 cafés through its joint venture with Tata Consumer Products. However, the new centre is expected to support Starbucks’ wider international operations rather than focus only on its Indian stores. For investors, the key question is whether the expansion can improve efficiency and customer engagement. Stronger digital systems could increase loyalty, support more personalised offers and help stores operate more effectively. The Chennai centre will not transform Starbucks on its own. It does, however, show that technology is becoming a more important part of how the company plans to improve its global business.

Accenture and Anthropic are committing at least $2 billion to AI model evaluation, positioning safety, reliability and independent oversight as a potentially valuable new market as businesses increase their use of advanced artificial intelligence. Accenture and Anthropic are committing at least $2 billion to AI model evaluation, betting that safety and reliability will become major markets as businesses adopt more advanced systems. The companies will each invest at least $1 billion over five years to develop independent testing capabilities. Accenture shares rose around 6% in Monday’s premarket trading as investors responded to the partnership and renewed interest in AI-related stocks. The programme will be led by Faculty, Accenture’s specialist AI business. Its teams will evaluate Anthropic’s models, test their safeguards and search for weaknesses before the technology is deployed more widely. The partnership comes as companies move beyond experimenting with AI and begin using it for important business operations. That transition is increasing demand for evidence that models are secure, accurate and dependable. Accenture and Anthropic plan to use an approach known as embedded evaluation. Independent specialists will work closely with developers and receive access similar to company employees, giving them greater visibility into how models are built and tested. This could offer businesses and regulators more confidence than assessments performed entirely by the company that developed the system. For Accenture, the agreement creates an opportunity to position itself between AI developers and the organisations adopting their technology. Companies want the productivity benefits of AI, but many remain concerned about inaccurate outputs, data security and regulatory exposure. Accenture could help clients identify those risks while advising them on how to introduce the technology safely. That service may prove especially valuable in regulated sectors such as finance, healthcare and energy, where an AI failure could carry significant financial, legal or reputational costs. However, the investment is not without risk. Accenture must prove that demand for model evaluation can generate meaningful revenue. Its close relationship with Anthropic could also raise questions about how independent the assessments will be in practice. The deal nevertheless shows how the AI economy is expanding beyond semiconductors, data centres and model development. As AI becomes more capable and more deeply embedded in business operations, companies may be willing to spend heavily on testing and oversight. Accenture is betting that trust will become one of the industry’s most valuable services.

SoftBank is raising approximately $11 billion through one of the year’s largest corporate bond sales, using debt markets to finance its expanding investment in OpenAI and the wider artificial intelligence boom. SoftBank is turning to the bond market to finance its growing artificial intelligence ambitions. The Japanese investment group has launched approximately $11 billion in dollar- and euro-denominated bonds. Most of the proceeds will fund the next stage of its investment in OpenAI. The offering includes $10 billion in US dollar bonds and €1 billion in euro bonds, spread across several maturities. If completed as planned, it would become the largest bond sale by a non-financial company in the Asia-Pacific and Japan region. SoftBank will use the proceeds to replace a $10 billion bridge loan arranged for its upcoming OpenAI payment. That investment tranche is expected to close on October 1. The transaction demonstrates how much capital is now being committed to artificial intelligence. OpenAI requires enormous funding to develop new models, secure computing capacity and expand its infrastructure. For SoftBank, the investment could provide substantial exposure to one of the world’s most valuable AI companies. However, financing that position with debt also increases the risk if OpenAI’s growth fails to meet expectations. Fitch assigned the proposed bonds a BB+ rating. The agency expects SoftBank’s debt to rise but believes the company still has strong liquidity and access to capital markets. The bond sale also tests investor appetite for financing the AI boom. Strong demand would suggest lenders remain willing to support major technology investments despite uncertainty over when the spending will produce sustainable returns. SoftBank has repeatedly made large, concentrated bets on emerging technologies. Its latest financing shows that OpenAI now sits at the centre of that strategy. For investors, the opportunity is significant, but so is the exposure. SoftBank is not simply investing in AI growth. It is placing billions of dollars behind OpenAI’s ability to deliver it.

Greenland-linked mining stocks surged after a diplomatic breakthrough renewed interest in the territory’s critical minerals, although investors still face major questions around financing, infrastructure, regulation and commercial development. Greenland-linked mining stocks have jumped after a diplomatic agreement between the United States, Denmark and Greenland renewed investor interest in the Arctic territory’s mineral potential. US-listed Critical Metals rose approximately 30% in early trading as markets responded to signs of improving cooperation between the countries. Greenland holds substantial deposits of rare earths and other critical minerals used in electric vehicles, defence equipment, renewable energy systems and advanced technology. Those resources have attracted growing attention as the United States and its allies look to reduce their dependence on China, which continues to dominate several important mineral supply chains. The latest diplomatic progress centres primarily on Arctic security rather than mining. However, investors appear to believe that closer cooperation could eventually support greater US involvement in Greenland’s infrastructure and resource development. That possibility has increased interest in companies with projects connected to the territory. However, the rally remains largely driven by expectations rather than a significant change in mining activity. Developing projects in Greenland can be expensive and difficult because of limited infrastructure, harsh weather and strict environmental requirements. Critical Metals and other Greenland-exposed companies must still secure financing, complete regulatory processes and demonstrate that their projects can operate commercially. This creates a clear divide between the territory’s strategic value and the practical challenge of extracting its resources. For investors, Greenland offers exposure to rising Western demand for secure supplies of critical minerals. However, sharp share-price movements can also reflect political developments and market speculation rather than improvements in a company’s underlying business. The diplomatic breakthrough has placed Greenland’s resources back in focus. The next test is whether that attention can translate into investment, construction and eventual production.

Visa is cutting around 2,600 jobs as it restructures its operations, even after reporting double-digit growth in revenue, payment volumes and processed transactions. Visa is cutting thousands of jobs, but the move comes as its payments business continues to grow. The company plans to eliminate around 2,600 positions, roughly 7% of its global workforce, with technology and product teams expected to take much of the impact. Visa says the restructuring will allow it to cut costs while redirecting investment towards faster-growing parts of the business. And the timing stands out. Visa reported a 14% increase in quarterly net revenue to $11.63 billion, while net profit reached $5.63 billion. Payment volumes climbed 10%, passing $4 trillion in a single quarter for the first time. Cross-border volumes, an important source of revenue for Visa, were also up 13%. Those numbers suggest Visa is not restructuring because its core business is under pressure. Consumers and businesses are still spending, international payments are growing and more transactions are moving through its network. Instead, Visa appears to be reshaping the company while growth remains strong. CEO Ryan McInerney said Visa needs to continue changing how it operates as the payments industry evolves. Investment is increasingly being directed towards areas including consumer payments, business transactions, stablecoins and other digital services. AI is also changing how some work is done inside the company, particularly repetitive tasks and parts of product development. But Visa has not presented automation as the sole reason behind the cuts. The wider goal is to operate more efficiently and concentrate employees and investment in areas with greater growth potential. That push is not unique to Visa. Mastercard has also announced workforce reductions as major payments companies face growing competition from digital wallets, fintech platforms, instant payments and emerging stablecoin services. Visa’s own costs are rising as well. Quarterly operating expenses increased 19% to $4.8 billion, including $563 million in severance expenses related to the restructuring. For investors, that creates an interesting contrast. Visa is processing record payment volumes and delivering double-digit revenue growth, yet management is still looking for a leaner cost structure.